Participant flow

Trimodal Lung-Sparing Treatment of Pleural Mesothelioma · Source last updated 2020-08-25

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Intrapleural chemotherapy plus systemic chemotherapy: Thoracoscopy to implant two intrapleural catheters followed by intrapleural chemotherapy with doxorubicin and cisplatin (weeks 1, 2, 4, 5, 7, and 8). Systemic chemotherapy treatments with cisplatin and pemetrexed during weeks 3, 6, and 9. Intrapleural radiotherapy with P-32 will be given 3 weeks after last dose of chemotherapy and 11 to 12 weeks after initial thoracoscopy. Doxorubicin: A medication used in cancer chemotherapy, derived by chemical semisynthesis from a bacterial species. Cisplatin: Platinum-based antineoplastic Pemetrexed: Folate Analog Metabolic Inhibitor Radiotherapy: Standard procedure given 3 weeks after last dose of chemotherapy

   id

   FG000

   title

   Multimodal Lung Sparing Regimen

periods

1. milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         9

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         9

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         0

      type

      NOT COMPLETED

   title

   Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice